Case no. | Group | Adverse events |
---|---|---|
1 | MPZ | None |
2 | MPZ | 2 M: bacterial bronchitis (improved) |
3 | MPZ | None |
4 | MPZ | None |
5 | MPZ | None |
6 | MPZ | 6 M: RS virus infection (improved) |
7 | MPZ | None |
8 | IVCY | 1 M: cytomegalovirus infection (hospitalization treatment, improved) 1.5 M: purulent arthritis (hospitalization treatment, discontinuation of IVCY) |
9 | IVCY | 3 w: candidemia (death, discontinuation of IVCY) |
10 | IVCY | None |
11 | IVCY | None |
12 | IVCY | 2 M: cytomegalovirus infection (hospitalization treatment, improved) 3 M: Aspergillus pneumonia, nocardia pneumonia (hospitalization treatment, improved) |
13 | IVCY | None |
14 | IVCY | 1.5 M: cytomegalovirus infection (hospitalization treatment, improved) 2 M: liver dysfunction (discontinuation of IVCY) |
15 | IVCY | None |
16 | IVCY | 1 M: cytomegalovirus infection (hospitalization treatment, improved) 1 M: liver dysfunction (discontinuation of IVCY) |
17 | IVCY | None |
18 | IVCY | None |
19 | IVCY | 2 w: cardiac dysfunction (discontinuation of IVCY) |
20 | IVCY | 4 M: bacterial bronchitis (improved) |